Artemis Medicare Q1 FY27: Revenue Up 12.7%, PAT Soars 48.3%
Artemis Medicare Services Ltd. reported Q1 FY27 consolidated revenue growth of 12.7% to ₹28,732 Lacs. PAT surged 48.3% to ₹3,144 Lacs, and EBITDA rose 27.9% to ₹6,182 Lacs. The company also commenced operations at its Raipur hospital in July 2026, marking a significant expansion step.
Significant double-digit growth in revenue and profit, coupled with the announcement of a new hospital commencing operations, is expected to have a substantial positive impact on investor sentiment and the company's future prospects.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with positive commentary from the Chairman and Managing Director regarding performance and expansion plans.
Artemis Medicare Services Ltd. announced its consolidated financial results for the quarter ended June 30, 2026, reporting a significant year-on-year increase in key financial metrics.
Consolidated revenue from operations grew by 12.7% to ₹28,732 Lacs compared to ₹25,496 Lacs in the same period last fiscal year. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) saw a robust rise of 27.9%, reaching ₹6,182 Lacs from ₹4,832 Lacs. Profit After Tax (PAT) surged by 48.3% to ₹3,144 Lacs, up from ₹2,120 Lacs in the prior year's first quarter. Diluted Earnings Per Share (EPS) also improved by 46.7%, standing at ₹1.98 compared to ₹1.35.
The company's flagship Artemis Hospital Gurgaon also demonstrated strong performance. Revenue from operations increased by 15.4% to ₹27,849 Lacs. EBITDA grew by 24.4% to ₹6,163 Lacs, and PAT rose by 32.7% to ₹3,306 Lacs. Bed capacity utilization improved to 65.7%, and the average revenue per occupied bed (ARPOB) was ₹85,690. Revenue from overseas patients increased by 8.6% to ₹7,651 Lacs, contributing 27.5% to the total revenue.
On a quarter-on-quarter basis, consolidated revenue from operations increased by 2.9% to ₹28,732 Lacs from ₹27,923 Lacs in Q4 FY26. EBITDA grew by 4.1% to ₹6,182 Lacs, and PAT increased by 3.8% to ₹3,144 Lacs. Diluted EPS rose by 4.2% to ₹1.98.
Mr. Onkar Kanwar, Chairman, Artemis Medicare Services Ltd., commented on the strong start to FY27, highlighting the resilience of the business model and disciplined execution. He also noted the commencement of operations at the Raipur hospital in July 2026 as an important milestone for expansion into high-growth markets.
Dr. Devlina Chakravarty, Managing Director, Artemis Medicare Services Ltd., emphasized the continued strength of the operational strategy, healthy revenue growth, improved margins, and strong profitability. She also mentioned the Raipur hospital's commencement of operations in July 2026 as the beginning of a new growth phase.
What to do with a filing like this
Artemis Medicare Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Artemis Medicare Services Limited. Read the original for the full detail.